[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369370-105":59,"doc-detail-369370-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","elevated-circulating-il-8-correlates-with-poor-prognosis-in-urological-cancers-a-meta-analysis-and-bioinformatic-validation","Elevated circulating IL-8 correlates with poor prognosis in urological cancers - a meta-analysis and bioinformatic validation","","Interleukin-8 (IL-8) is a key cytokine linked to cancer progression and resistance, with higher circulating IL-8 (cIL-8) levels associated with worse clinical outcomes in urological cancers. However, consolidated definitive evidence is limited. This study synthesizes prognostic research on cIL-8 in urological patients using pooled hazard ratios for overall and progression-free survival, followed by Kaplan–Meier validation via TCGA RNA-seq analysis using GEPIA 2.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/elevated-circulating-il-8-correlates-with-poor-prognosis-in-urological-cancers-a-meta-analysis-and-bioinformatic-validation/369370/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/elevated-circulating-il-8-correlates-with-poor-prognosis-in-urological-cancers-a-meta-analysis-and-bioinformatic-validation/369370.png","ImageObject",300,407,{"name":92,"@type":93},"Margaret","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does this meta-analysis address?","Question",{"text":112,"@type":113},"It evaluates whether elevated circulating IL-8 levels predict poor prognosis in patients with urological cancers by synthesizing existing prognostic studies and validating the associations with bioinformatic survival analyses.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were prognostic effects measured in the study?",{"text":117,"@type":113},"Hazard ratios for overall survival and progression-free survival were extracted from included cohorts and pooled to estimate the overall prognostic impact of cIL-8.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about elevated cIL-8 levels?",{"text":121,"@type":113},"Elevated cIL-8 was significantly associated with inferior overall survival and progression-free survival, and the results were supported by Kaplan–Meier survival analyses using GEPIA 2.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369370,1790652400,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","AnnAls of Medicine  \n2025, Vol. 57, no. 1, 2486592  \n[https://doi.org/10.1080/07853890.2025.2486592](https://doi.org/10.1080/07853890.2025.2486592)  \nRESEARCH ARTICLE     \nElevated circulating IL-8 correlates with poor prognosis in urological cancers: a meta-analysis and bioinformatic validation  \nYuxuan Lina, Yonghe Liaob, Mengfan Huangc,d and Jinhai Shenc,d   \nadepartment of Pharmacy, Guangxi Hospital division of The first Affiliated Hospital, sun Yat-sen University, nanning, PR china; bcollege of Pharmaceutical science, Guangxi Medical University, nanning, PR china; cstate Key laboratory of natural Medicines, china Pharmaceutical University, nanjing, PR china; dcenter for new drug safety evaluation and Research, china Pharmaceutical University, nanjing, PR china  \nABSTRACT  \nBackground: Interleukin-8 (IL-8) is a key cytokine that has been implicated in multiple aspects of cancer progression and therapeutic resistance. Elevated levels of circulating IL-8 (cIL-8) have been implicated in adverse clinical outcomes among patients with urological cancers. However, definitive evidence consolidating these observations remains lacking. The present study aims to synthesize the existing research findings to provide a comprehensive, evidence-based reference for clinical practice.  \nMethods: A systematic literature search was conducted to identify relevant studies that reported on the prognostic impact of cIL-8 levels in urological cancer patients. Hazard ratios (HRs) for overall survival (OS) and progression-free survival (PFS) were extracted and pooled to estimate the overall effect. Furthermore, Kaplan–Meier’s survival analyses were conducted using RNA-seq data from The Cancer Genome Atlas (TCGA) through the Gene Expression Profiling Interactive Analysis 2 (GEPIA 2) online tool to validate the observed associations.  \nResults: A total of 19 cohorts encompassing 2740 patients from 12 studies were included in the meta-analysis. The findings revealed that elevated cIL-8 levels were significantly associated with inferior OS (HR: 1.86; 95% confidence intervals (CI): 1.72–2.02) and PFS (HR: 1.59; 95%CI: 1.25–2.03) in patients with urological cancers. The consistency and validity of these results were further supported by survival analyses performed using the GEPIA 2 tool.  \nConclusions: This study, which is the first meta-analysis to systematically examine the prognostic significance of cIL-8 in urological cancers, supported by bioinformatics validation, confirms that elevated cIL-8 levels serve as a potential biomarker for predicting adverse outcomes. Our findings underscore the importance of targeting IL-8 as a therapeutic strategy to overcome treatment resistance and improve outcomes for urological cancer patients. Further research into IL-8-targeted therapies and their integration into clinical practice is urgently needed to enhance the treatment landscape for urological cancers.  \nARTICLE HISTORY  \nReceived 3 October 2024 Revised 27 January 2025 Accepted 20 March 2025  \nKEYWORDS  \nInterleukin-8; urological cancers; biomarker; prognosis; meta-analysis  \nIntroduction  \nUrological cancers, encompassing a spectrum of malignancies affecting the genitourinary system, pose a formidable health challenge globally [1] . The mortality rates associated with these cancers, including urothelial carcinoma (UC) and renal cell carcinoma (RCC), underscore the urgency for precision medicine approaches to improve patient outcomes. The advent of targeted therapies and immunotherapies has heralded a new  \nera in urological cancer treatment, offering hope for patients with advanced disease [2,3] . However, the emergence of treatment resistance remains a significant hurdle in achieving optimal therapeutic responses for all patients [4,5] . Therefore, a deeper understanding of the mechanisms driving treatment resistance is crucial for the identification of predictive biomarkers, which can inform personalized treatment approaches and ultimately enhance patient","cbCaio8ao67zafJs","https://ap.wps.com/l/cbCaio8ao67zafJs","pdf",5606343,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Clinical context and rationale\n# Materials and validation\n## Kaplan–Meier analysis via GEPIA 2","[{\"question\":\"What question does this meta-analysis address?\",\"answer\":\"It evaluates whether elevated circulating IL-8 levels predict poor prognosis in patients with urological cancers by synthesizing existing prognostic studies and validating the associations with bioinformatic survival analyses.\"},{\"question\":\"How were prognostic effects measured in the study?\",\"answer\":\"Hazard ratios for overall survival and progression-free survival were extracted from included cohorts and pooled to estimate the overall prognostic impact of cIL-8.\"},{\"question\":\"What did the study find about elevated cIL-8 levels?\",\"answer\":\"Elevated cIL-8 was significantly associated with inferior overall survival and progression-free survival, and the results were supported by Kaplan–Meier survival analyses using GEPIA 2.\"}]","Elevated circulating IL-8 correlates with poor prognosis in urological cancers - a meta-analysis and bioinformatic validation | PDF",1790182285,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ff8f30ddb840026674c9bff359fe95f.webp",983,1280,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae66c34ed00470b6af95c24a25d7e75b.webp",982,1278,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/330ab24fde28efa5555c4e52c44bbacc.webp",981,1277,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee02536fb42f8adaa51946b98e2eb3b9.webp",980,1276]